OverviewChartNewsTraderScreen

Goldman Sachs Knock-Out PGR/  DE000GG413L9  /

EUWAX
9/19/2024  9:43:29 PM Chg.-0.26 Bid9:59:55 PM Ask9:59:55 PM Underlying Strike price Expiration date Option type
6.00EUR -4.15% 6.01
Bid Size: 1,000		 6.16
Ask Size: 1,000		 Progressive Corporat... 188.9485 USD 12/31/2078 Call
Newsfile Corp 9/19 Immunotherapy Clinical Trials - A New Approach to Treating Cancer
Newsfile Corp 9/17 Innovation Driving Cancer's Solid Tumors Market
GlobeNewswire 9/2 Press Release: Tolebrutinib meets primary endpoint in HERCULES phase 3 study, the first and only to ...
GlobeNewswire 8/30 MediciNova Receives Notice of Allowance from United States Patent and Trademark Office for New Paten...
GlobeNewswire 8/30 Emergent BioSolutions’ ACAM2000®, (Smallpox and Mpox (Vaccinia) Vaccine, Live) Receives U.S. FDA App...
GlobeNewswire 8/29 The Alignment Studio Announces Launch of Women’s Health Physiotherapy Services in Melbourne
GlobeNewswire 8/28 AC Immune’s PI-2620 Tau-PET Diagnostic in Phase 3 Receives Fast Track Designation in Three Neurodege...
GlobeNewswire 8/26 Avalyn Announces Upcoming Presentations on its Lead Program AP01, Inhaled Pirfenidone, for the Treat...
GlobeNewswire 8/22 Abata Therapeutics Receives FDA Fast Track Designation for ABA-101 for the Treatment of Progressive ...
GlobeNewswire 8/21 CPAClub™ and Caseware™ Partner to Elevate Audit Quality for Progressive Accounting Firms
GlobeNewswire 8/19 Emergent BioSolutions Responds to Mpox Public Health Emergency as Cases Surge in Africa
GlobeNewswire 8/19 Tiziana Life Sciences Appoints New Chief Executive Officer
GlobeNewswire 8/19 Fulcrum Therapeutics Strengthens Leadership Team with the Appointments of Isabel Kalofonos as Chief ...
GlobeNewswire 8/19 CN Issues Lockout Notice to Teamsters
GlobeNewswire 8/15 Abata Therapeutics Announces Strategic Investment from Bristol Myers Squibb Supporting Advancement o...
GlobeNewswire 8/14 Progressive Reports July 2024 Results
GlobeNewswire 8/14 Atsena Therapeutics Receives Rare Pediatric Disease Designation from the U.S. FDA for ATSN-201 Gene ...
GlobeNewswire 8/14 Tiziana Life Sciences Regains Compliance with Nasdaq Listing Minimum Bid Price Rule
GlobeNewswire 8/13 Eyenovia to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference
GlobeNewswire 8/12 Eyenovia Reports Second Quarter 2024 Financial Results and Provides Corporate Update
Newsfile Corp 8/12 The Cancer Battle - How Smaller Companies Are Making Big Advancements in Treatments for Solid Tumors
TeleTrader 8/11 Bank of Russia says rates could reach 20%
GlobeNewswire 8/8 Opthea to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference, August 15,...
GlobeNewswire 8/8 Eyenovia to Report Second Quarter 2024 Results on Monday, August 12th
GlobeNewswire 8/7 Eyenovia and Formosa Pharmaceuticals Initiate Co-Development of Clobetasol Propionate Ophthalmic Sus...